|By JCN Newswire||
|December 25, 2013 11:07 PM EST||
The irradiation of tumors with beams of accelerated particles (protons or carbon ions) has become recognized as a new form of cancer treatment. With a high incidence of cancer comparable to Japan or Europe, Russia is planning the construction of a number of new particle beam therapy facilities to strengthen its capabilities for treatment of the disease.
Backed by more than 20 years of history and tradition in Moscow, GEMC is one of the largest private medical service companies in Russia, operating 24-hour emergency clinics, pediatric hospitals, and women's hospitals at 5 locations in Moscow. The company is growing by creating private medical facilities, and providing them modern medical management and services in Moscow.
In April 2013, Hitachi entered into a strategic partnership with GEMC and the Budker Institute of Nuclear Physics (BINP) aimed at promoting the construction of hadron therapy systems in Russia. The new MOU announced today represents the first project to be initiated under this partnership. In addition to collaborating on construction through the supply of technical documents and other resources required for the building design, Hitachi will also be entering into exclusive negotiations toward a formal contract for supply of the system. It is expected that the contract will be signed by the end of March 2014.
Hitachi started developing proton beam therapy systems approximately 20 years ago. The technology has earned widespread recognition as an effective cancer treatment, with systems having been supplied to the University of Tsukuba and Nagoya Proton Therapy Center in Japan. Outside Japan, Hitachi has supplied a system to the MD Anderson Cancer Center in the USA, one of the world's largest specialist cancer hospitals. Particle beam therapy systems for Hokkaido University and three well-known clinics in the USA are currently under construction.
In addition to making an ongoing contribution to the wider adoption of advanced radiation therapy and other cancer treatments through the supply of particle beam therapy systems that incorporate leading-edge technologies such as spot scanning, Hitachi is also committed to the global operation of its healthcare and other social innovation businesses.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 320,000 employees worldwide. Fiscal 2011 (ended March 31, 2012) consolidated revenues totaled 9,665 billion yen ($117.8 billion). Hitachi will focus more than ever on the Social Innovation Business, which includes information and telecommunication systems, power systems, environmental, industrial and transportation systems, and social and urban systems, as well as the sophisticated materials and key devices that support them. For more information on Hitachi, please visit the company's website at http://www.hitachi.com/.
Hitachi Ltd Corporate Communications Tel: +81-3-3258-1111
Copyright 2013 JCN Newswire. All rights reserved. www.japancorp.net
May. 2, 2016 06:30 AM EDT Reads: 2,508
May. 2, 2016 06:00 AM EDT Reads: 1,269
May. 2, 2016 04:30 AM EDT Reads: 1,754
May. 1, 2016 11:00 PM EDT Reads: 1,593
May. 1, 2016 08:00 PM EDT Reads: 1,846
May. 1, 2016 07:00 PM EDT Reads: 765
May. 1, 2016 06:00 PM EDT Reads: 815
May. 1, 2016 06:00 PM EDT Reads: 1,169
May. 1, 2016 05:00 PM EDT Reads: 1,035
May. 1, 2016 04:30 PM EDT Reads: 1,483
May. 1, 2016 04:00 PM EDT Reads: 957
May. 1, 2016 03:15 PM EDT Reads: 1,043
May. 1, 2016 01:30 PM EDT Reads: 1,582
May. 1, 2016 01:30 PM EDT Reads: 823